CLNN

Clene Inc.

Price

$4.22

return (12m)

-22.00%

p/e

-1.35

p/bv

-2.15

DIVIDEND YIELD

0.00%

CLNN price

Clene

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment CLNN

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-16.77%

3 months

-35.91%

1 year

-22.00%

2 years

-25.31%

5 years

-97.27%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals CLNN

Valuation

P/E

-1.35

Sector -4.26

Industry -4.26

P/BV

-2.15

Sector 2.11

Industry 2.11

P/Revenue (PSR)

253.43

Sector 2.08

Industry 2.08

EV/EBITDA

Sector -546.19

Industry -546.19

EV/EBIT

Sector -37.31

Industry -37.31

P/EBITDA

Sector -50.76

Industry -50.76

P/EBIT

Sector -39.62

Industry -39.62

P/Total Assets

2.31

Sector 1.25

Industry 1.25

P/Net Current Assets

-1.62

Sector -5.47

Industry -5.47

P/Working Capital

5.29

Sector -1.10

Industry -1.10

EPS

-3.29

Sector -1.94

Industry -1.94

BVPS

-2.07

Sector 1.89

Industry 1.89

Efficiency

Gross Margin

66.67%

Sector 38.90%

Industry 38.90%

EBITDA Margin

0.00%

Sector -13,872.56%

Industry -13,872.56%

EBIT Margin

0.00%

Sector -4,253,834.43%

Industry -4,253,834.43%

Operating Margin

-100.00%

Sector -36.74%

Industry -36.74%

Net Profit Margins

-100.00%

Sector -37.51%

Industry -37.51%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

159.48%

Sector -61.50%

Industry -61.50%

ROA

-171.53%

Sector -63.85%

Industry -63.85%

ROIC

0.00%

Sector -498.30%

Industry -498.30%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

3.07

Sector 2.89

Industry 2.89

Net Debt / EBITDA

Sector -39,048,222.71

Industry -39,048,222.71

Net Debt / EBIT

Sector -10.24

Industry -10.24

Net Debt / Equity

-0.52

Sector -0.60

Industry -0.60

Gross Debt / Equity

-0.52

Sector -0.83

Industry -0.83

Equity/Assets

-1.08

Sector 0.43

Industry 0.43

Liabilities/Assets

2.08

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

-21.84%

Sector -

Industry -

5Y Earnings CAGR

32.30%

Sector -

Industry -

Fundamentals CLNN

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
CLNN Clene Inc.	$4.22	-21.56%	0.00%	-1.35	-2.15	159.48%	-100.00%
JNJ Johnson & Johnson	$266.50	55.29%	1.93%	31.09	7.70	24.76%	21.48%
PFE Pfizer Inc.	$27.87	21.03%	6.26%	35.86	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$256.91	27.42%	2.58%	74.16	-78.93	-106.44%	9.81%
NVO Novo Nordisk A/S	$45.62	-14.65%	3.95%	11.47	6.09	53.11%	35.32%
MRK Merck & Co. Inc.	$147.77	82.61%	2.24%	116.78	8.81	7.55%	4.76%
AZN AstraZeneca PLC	$161.98	3.71%	1.93%	24.59	5.10	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$66.29	45.78%	3.73%	14.81	6.16	41.55%	18.85%
ZTS Zoetis Inc.	$76.84	-49.43%	2.67%	12.20	10.25	84.02%	27.77%
REGN Regeneron Pharmaceuticals Inc.	$792.43	37.47%	0.44%	19.71	2.69	13.65%	27.86%
AMGN Amgen Inc.	$432.42	55.55%	2.22%	27.25	20.39	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$105.00	43.48%	0.00%	30.73	88.55	288.14%	24.86%
MCK McKesson Corporation	$897.16	31.93%	0.38%	19.60	-26.88	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$542.40	39.41%	0.00%	31.57	6.87	21.76%	35.00%
CAH Cardinal Health Inc.	$235.19	59.60%	0.88%	35.20	-20.39	-57.93%	0.62%
HRMY Harmony Biosciences Holdings Inc.	$39.29	3.26%	0.00%	12.32	2.23	18.14%	18.89%
BIIB Biogen Inc.	$217.24	59.31%	0.00%	38.68	1.71	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

CLNN Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Clene

Clene Inc.

Average Investor10 user rating

4.0 (0 people)

United States

13 years

Founded: 2013

2020

Time since IPO - 6 years

-

Employees

Clene Inc. (United States) is listed on the Nasdaq and has a market capitalization of $53.22 million, with shareholders equity totaling $-24.78 million.

The Company is listed on the [MARKET_NAME]

Over the past 12 months, Clene Inc. reported $210.00 Thousand in revenue, generating net income of $-39.52 million.

Key financial metrics include a P/E ratio of -1.35, a price-to-book (P/B) ratio of -2.15, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CLNN.

Market cap

$53.22 million

Net worth

$-24.78 million

$-24,780,000.00

Assets

$23.04 million

$23,040,000.00

Total Shares Outstanding

12.00 million

12,000,000

Average Daily Trading Volume

Sector

Health Care

Industry

Biotechnology

CLNN

CLNN revenue and profits

Financial Results CLNN

DRAG THE FRAME TO SEE MORE DATA

CLNN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$897.16 31,33% (12M)

P/E

19.60

0.38%

ROE

-137.16%

P/BV

-26.88

CAH - Cardinal Health

$235.19 60,10% (12M)

P/E

35.20

0.88%

ROE

-57.93%

P/BV

-20.39

JNJ - Johnson & Johnson

$266.50 54,96% (12M)

P/E

31.09

1.93%

ROE

24.76%

P/BV

7.70

ABBV - AbbVie

$256.91 26,00% (12M)

P/E

74.16

2.58%

ROE

-106.44%

P/BV

-78.93

MRK - Merck & Co.

$147.77 82,50% (12M)

P/E

116.78

2.24%

ROE

7.55%

P/BV

8.81

AZN - AstraZeneca

$161.98 3,46% (12M)

P/E

24.59

1.93%

ROE

20.74%

P/BV

5.10

PFE - Pfizer

$27.87 22,54% (12M)

P/E

35.86

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$897.16 31,33% (12 M)

P/L

19.60

0.38%

ROE

-137.16%

P/VP

-26.88

CAH - Cardinal Health

$235.19 60,10% (12 M)

P/L

35.20

0.88%

ROE

-57.93%

P/VP

-20.39

JNJ - Johnson & Johnson

$266.50 54,96% (12 M)

P/L

31.09

1.93%

ROE

24.76%

P/VP

7.70

ABBV - AbbVie

$256.91 26,00% (12 M)

P/L

74.16

2.58%

ROE

-106.44%

P/VP

-78.93

MRK - Merck & Co.

$147.77 82,50% (12 M)

P/L

116.78

2.24%

ROE

7.55%

P/VP

8.81

AZN - AstraZeneca

$161.98 3,46% (12 M)

P/L

24.59

1.93%

ROE

20.74%

P/VP

5.10

PFE - Pfizer

$27.87 22,54% (12 M)

P/L

35.86

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Clene (CLNN) today?

A cotação de Clene (CLNN) hoje está em US$ 4.22, com uma variação de -22% em relação ao último ano. A cotação de Clene (CLNN) iniciou o ano negociando na casa dos US$ 5.87 e hoje está em US$ 4.22. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Clene (CLNN) e dados de ações do Ibovespa e mercados internacionais.

Quando Clene (CLNN) paga dividendos?

Clene (CLNN) não distribuiu dividendos no último ano.

Is Clene (CLNN) a good investment?

Atualmente, Clene (CLNN) está cotada a US$ 4.22, com um P/L de -1.35, representando um desvio de -1,351% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de -22 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de -22.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Clene (CLNN) stock?

Investir em ações de Clene (CLNN) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Clene (CLNN) yield today?

A rentabilidade de Clene (CLNN) foi de -16.77% no último mês, -22.00% no último ano e -97.27% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Clene (CLNN) hoje, o investimento total seria de US$ 422.00, com base na cotação atual de US$ 4.22.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 329.16
Em 5 anos: US$ 11.52
Em 10 anos: US$ 422.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

CLNN

Clene Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment CLNN

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING CLNN WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Clene

Clene Inc.

United States

13 years

2020

-

PROFIT X PRICE CLNN

Financial Results CLNN

CLNN cash flow

Asset, Revenue and Profit Growth - CLNN

CLNN balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions